MedTrace Logo

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

NCT01703000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-04-15

Study results available
· View outcomes & findings →

Summary

NG PROMUS: A Prospective, Multicenter Trial to Assess the NG PROMUS Everolimus-Eluting Platinum Chromium Coronary Stent System (NG PROMUS Stent System) for the Treatment of Atherosclerotic Lesion(s)

Conditions

Interventions

DEVICE

Percutaneous coronary intervention (NG PROMUS)

Interventional coronary artery stenting with NG PROMUS study stent.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • John A Ormiston, MBChB, FRACP, FRACR · Mercy Angiography Unit, Ltd. Mercy Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Australia
  • New Zealand
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01703000 on ClinicalTrials.gov